Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation With Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis
Author: Bittar, LF
de Paula, EV
Mello, TBT
Siqueira, LH
Orsi, FLA
Annichino-Bizzacchi, JM
Abstract: Background: Increased levels of factor VIII (FVIII) are a prevalent and independent risk factor for deep venous thrombosis (DVT) and are affected by von Willebrand factor (vWF) levels. Design and Methods: ADAMTS13 contributes to vWF levels, and we investigated genetic polymorphisms previously described to be associated with decreased levels of these proteins in 435 patients with DVT (126 M and 309 F; median age 37 years, range 18-68 years) and 580 controls (163 M and 417 F; median age 35 years, range 18-68 years). Subsequently, we investigated the relationship between the genotypes and plasma levels of FVIII, vWF, and DVT risk. Results: Patients with DVT showed higher plasma levels of FVIII: C, FVIII:Ag, and vWF: Ag (P < .001) when compared to controls. Patients and controls heterozygous for the 4751A>G polymorphism in the vWF gene presented decreased levels of vWF: Ag, FVIII: Ag, and FVIII: C (P < .001), but this was not a protective factor for DVT. Individuals heterozygous for 1852C>G polymorphism in ADAMTS13 gene, which is associated with reduced levels of ADAMTS13, had significantly elevated levels of vWF: Ag (P = .001), FVIII: Ag (P = .01), and FVIII: C (P = .02). However, this polymorphism was not a risk factor for DVT in our study. Heterozygosis for a new polymorphism identified in ADAMTS13 gene, 1787-26G>A, was significantly associated with elevated levels of FVIII: C (P = .02) when compared to wild type. Conclusions: Despite the tempting assumption that genetic factors that change ADAMTS13 activity might modulate the risk of DVT by altering vWF and FVIII levels, the polymorphisms analyzed in this study did not correlate with DVT risk among patients investigated.
Subject: ADAMTS13
deep venous thrombosis
factor VIII
von Willebrand factor
Country: EUA
Editor: Sage Publications Inc
Citation: Clinical And Applied Thrombosis-hemostasis. Sage Publications Inc, v. 17, n. 5, n. 514, n. 518, 2011.
Rights: fechado
Identifier DOI: 10.1177/1076029610375815
Date Issue: 2011
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000295613900013.pdf133.19 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.